MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 142 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q1 2016. The put-call ratio across all filers is 0.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $32,000 | -27.3% | 25,442 | +138.2% | 0.00% | -20.0% |
| Q4 2016 | $44,000 | +450.0% | 10,681 | +968.1% | 0.01% | +400.0% |
| Q1 2016 | $8,000 | +60.0% | 1,000 | +66.7% | 0.00% | 0.0% |
| Q4 2015 | $5,000 | -97.0% | 600 | -96.9% | 0.00% | -93.8% |
| Q3 2015 | $166,000 | +49.5% | 19,539 | +118.4% | 0.02% | +60.0% |
| Q2 2015 | $111,000 | +11000.0% | 8,948 | +8848.0% | 0.01% | – |
| Q1 2015 | $1,000 | -95.0% | 100 | -94.3% | 0.00% | -100.0% |
| Q4 2014 | $20,000 | +122.2% | 1,763 | -5.0% | 0.00% | +100.0% |
| Q1 2014 | $9,000 | +200.0% | 1,856 | +235.0% | 0.00% | 0.0% |
| Q4 2013 | $3,000 | -86.4% | 554 | -90.6% | 0.00% | -50.0% |
| Q3 2013 | $22,000 | +4.8% | 5,913 | +86.6% | 0.00% | 0.0% |
| Q2 2013 | $21,000 | – | 3,168 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 5,000,000 | $20,400,000 | 4.19% |
| Consonance Capital Management LP | 9,067,998 | $36,997,000 | 4.06% |
| Lagoda Investment Management, L.P. | 1,522,529 | $6,212,000 | 2.13% |
| INDUS CAPITAL PARTNERS, LLC | 1,050,000 | $4,284,000 | 0.56% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 9,072,877 | $37,017,000 | 0.32% |
| GARRISON BRADFORD & ASSOCIATES INC | 77,700 | $317,000 | 0.29% |
| Cannell & Co. | 1,572,978 | $6,418,000 | 0.23% |
| Virtus ETF Advisers LLC | 179,625 | $733,000 | 0.22% |
| LeJeune Puetz Investment Counsel LLC | 3,976 | $161,000 | 0.12% |
| STONERIDGE INVESTMENT PARTNERS LLC | 221,838 | $905,000 | 0.12% |